Simon Dingemans Buys 25,000 Shares of Avantor (NYSE:AVTR) Stock

Avantor, Inc. (NYSE:AVTR) Director Simon Dingemans purchased 25,000 shares of the stock in a transaction that occurred on Friday, May 1st. The stock was acquired at an average cost of $8.14 per share, for a total transaction of $203,500.00. Following the completion of the acquisition, the director owned 25,000 shares in the company, valued at $203,500. This represents a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Avantor Trading Up 5.0%

Shares of AVTR opened at $8.45 on Thursday. The firm has a market cap of $5.77 billion, a P/E ratio of -10.43, a price-to-earnings-growth ratio of 4.70 and a beta of 0.94. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.17. Avantor, Inc. has a 1 year low of $7.26 and a 1 year high of $15.93. The company has a 50 day simple moving average of $8.11 and a two-hundred day simple moving average of $10.37.

Avantor (NYSE:AVTR) last posted its earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.01. The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.54 billion. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. Avantor’s quarterly revenue was up .0% on a year-over-year basis. During the same period last year, the company posted $0.23 earnings per share. On average, equities analysts expect that Avantor, Inc. will post 0.79 earnings per share for the current fiscal year.

Institutional Trading of Avantor

A number of institutional investors have recently bought and sold shares of AVTR. Dodge & Cox increased its position in Avantor by 0.3% during the third quarter. Dodge & Cox now owns 117,746,888 shares of the company’s stock valued at $1,469,481,000 after acquiring an additional 313,404 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Avantor by 1.8% in the 3rd quarter. Vanguard Group Inc. now owns 65,988,977 shares of the company’s stock worth $823,542,000 after acquiring an additional 1,135,279 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC boosted its stake in shares of Avantor by 10.8% during the 3rd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 34,548,129 shares of the company’s stock worth $431,161,000 after purchasing an additional 3,356,861 shares during the period. Wellington Management Group LLP bought a new position in Avantor during the 4th quarter valued at about $268,584,000. Finally, Greenhaven Associates Inc. grew its holdings in Avantor by 12.0% during the 4th quarter. Greenhaven Associates Inc. now owns 20,500,653 shares of the company’s stock valued at $234,937,000 after purchasing an additional 2,189,083 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Wells Fargo & Company decreased their target price on Avantor from $16.00 to $14.00 and set an “overweight” rating on the stock in a research report on Friday, February 13th. TD Cowen restated a “hold” rating on shares of Avantor in a report on Thursday, February 12th. UBS Group reaffirmed a “neutral” rating and issued a $10.50 price objective on shares of Avantor in a research note on Thursday, February 12th. Evercore set a $10.00 target price on Avantor in a research report on Wednesday, February 11th. Finally, Citigroup cut their target price on shares of Avantor from $11.00 to $9.00 and set a “neutral” rating for the company in a report on Thursday, April 30th. Three investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $11.39.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.